Keyphrases
Clear Cell Sarcoma
100%
Combination Therapy
16%
Downstream Molecules
16%
Effective Treatment
16%
Histone Deacetylase 1 (HDAC1)
50%
Histone Deacetylase Inhibitor (HDACi)
100%
HLA Class I Molecules
100%
Immune Checkpoint Inhibitors
66%
Immunogenicity
33%
IRF1
100%
Isoform-specific
16%
Knockdown
16%
Melanocytic Nevus
16%
Melanoma
66%
Novel Therapeutics
16%
PD-L1 Expression
16%
Poor Prognosis
16%
Programmed Death-ligand 1 (PD-L1)
16%
Sarcoma
16%
Sarcoma Cells
100%
Small Interfering RNA (siRNA)
16%
SOX10
100%
Specific Inhibition
16%
Medicine and Dentistry
Clear-Cell Sarcoma
100%
Combination Therapy
16%
Connective Tissue Cancer
16%
HDAC1
33%
Histone Deacetylase
16%
Histone Deacetylase Inhibitor
100%
Immune Checkpoint Inhibitor
66%
Immunogenicity
33%
Interferon Regulatory Factor 1
100%
Melanoma
66%
Programmed Death-Ligand 1
33%
Sarcoma Cell
100%
Small Interfering RNA
16%
Immunology and Microbiology
Histone
100%
Immunogenicity
33%
Interferon Regulatory Factor 1
100%
Melanoma Cell
16%
Programmed Death-Ligand 1
33%
Sarcoma Cell
100%
Pharmacology, Toxicology and Pharmaceutical Science